GNH USA

Europe — EMA

Metformina + Sitagliptina Sandoz (Metformin Hydrochloride, Sitagliptin)

GNH USA supplies Metformina + Sitagliptina (Metformin, Sitagliptin), a Biguanide and DPP‑4 inhibitor for type 2 diabetes mellitus.

Metformin Hydrochloride, Sitagliptin

Request sourcing

1
Pack/s

What is Metformin Hydrochloride, Sitagliptin?

Metformin Hydrochloride and Sitagliptin, the active ingredient in Metformina + Sitagliptina Sandoz, is a Biguanide and DPP‑4 inhibitor presented as a tablet for oral use. It treats type 2 diabetes mellitus in adults by improving glycemic control.

GNH USA supplies Metformina + Sitagliptina Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Metformin Hydrochloride, Sitagliptin used for?

Metformina + Sitagliptina Sandoz is indicated for management of type 2 diabetes mellitus, targeting hyperglycemia through complementary mechanisms.

- Type 2 diabetes mellitus: improves overall glycemic control when used with diet and exercise. - Combination therapy with other oral antidiabetics: provides additional glucose‑lowering effect. - Inadequate control on metformin alone: adds sitagliptin to achieve target HbA1c levels.

What are the side effects of Metformin Hydrochloride, Sitagliptin?

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: frequent loose stools. - Abdominal discomfort: cramping or pain. - Headache: transient tension-type. - Mild hypoglycemia: especially when combined with insulin or sulfonylureas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe hypoglycemia: marked low blood glucose requiring assistance. - Pancreatitis: acute inflammation of the pancreas. - Severe allergic reactions: rash, angioedema, anaphylaxis. - Hepatic dysfunction: elevated liver enzymes. - Renal impairment: worsening kidney function.

What precautions apply to Metformin Hydrochloride, Sitagliptin?

Metformina + Sitagliptina Sandoz should be used with careful clinical monitoring. - Renal function: assess before initiation and monitor regularly. - Hepatic function: evaluate liver enzymes prior to therapy. - Cardiovascular disease: use cautiously in patients with heart failure. - Elderly patients: start at lower dose and monitor for accumulation. - Pregnancy and lactation: only if potential benefit justifies potential risk. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

What does Metformin Hydrochloride, Sitagliptin interact with?

Metformina + Sitagliptina Sandoz may interact with several medicines.

Major Interactions (Avoid): - Severe renal impairment: increased risk of metformin accumulation. - Concomitant use with other DPP‑4 inhibitors: duplicate pharmacologic effect. - Co‑administration with insulin or sulfonylureas: heightened hypoglycemia risk.

Moderate Interactions (Monitor Closely): - Iodinated contrast studies: temporary discontinuation of metformin recommended. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise sitagliptin plasma levels.

Frequently asked questions

What is Metformina + Sitagliptina Sandoz used for?+
Metformina + Sitagliptina Sandoz is prescribed for adults with type 2 diabetes mellitus to improve blood glucose control when diet, exercise, and lifestyle measures alone are insufficient.
How does Metformin Hydrochloride work in this combination?+
Metformin Hydrochloride reduces hepatic glucose production and increases peripheral insulin sensitivity, helping lower fasting and post‑prandial blood sugar levels.
What is the usual dose of Metformina + Sitagliptina Sandoz?+
The specific dose and dosing schedule are determined by the prescribing healthcare professional based on individual patient factors such as renal function, glycemic targets, and concomitant therapies.
Is Metformina + Sitagliptina Sandoz safe during pregnancy or breastfeeding?+
Safety in pregnancy and lactation has not been fully established. It should only be used if the potential benefit outweighs any possible risk to the mother or infant, and under close medical supervision.
How do I order Metformina + Sitagliptina Sandoz from GNH USA?+
Submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does this product compare with other antidiabetic options?+
Metformina + Sitagliptina combines a Biguanide (metformin) with a DPP‑4 inhibitor (sitagliptin), offering dual mechanisms that can be more effective than metformin alone and avoid the weight gain associated with some other agents such as sulfonylureas.
What are the storage and handling requirements for this medication?+
Store the tablets at ambient temperature, below 25 °C, in the original container. Protect from moisture and direct sunlight to maintain product stability.
How is Metformina + Sitagliptina Sandoz administered?+
The medication is taken orally, usually with meals to reduce gastrointestinal discomfort. Patients should follow the prescribing clinician’s instructions regarding timing and any dose adjustments.
What are the most serious risks associated with this therapy?+
Serious risks include lactic acidosis (especially in patients with renal impairment), severe hypoglycemia when combined with insulin or sulfonylureas, and rare cases of pancreatitis or allergic reactions requiring immediate medical attention.
Who should not use Metformina + Sitagliptina Sandoz?+
Patients with severe renal impairment, known hypersensitivity to metformin or sitagliptin, or those with a history of lactic acidosis should avoid this medication. Contraindications are confirmed by the prescribing clinician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Metformin Hydrochloride, Sitagliptin
Route
Oral Use
Manufacturer
Sandoz Farmacêutica Lda.
Origin
EU

Related products

Adiabin

Adiabin

Metformin Hydrochloride, Sitagliptin

Pharmextracta S.P.A
EU
Ansifora Duo

Ansifora Duo

Metformin Hydrochloride, Sitagliptin

Vipharm S.A.
EU
Ansifora Duo

Ansifora Duo

Metformin Hydrochloride, Sitagliptin

Vipharm S.A.
EU
Ansifora Duo

Ansifora Duo

Metformin Hydrochloride, Sitagliptin

Vipharm S.A.
EU